Company news

Racura Oncology Ltd news in 2020

Racura Oncology Ltd's news releases, calls and decks from 2020, newest first.

View company

Race receives $387k R&D tax incentive refund

December 16, 2020

Race AGM presentations and strategic update

November 29, 2020

Impressive Preclinical Bisantrene Breast Cancer Results

November 23, 2020

Prof Borje S Andersson appointed Chief Medical Officer

October 1, 2020

Race leadership team strengthened

September 1, 2020

Strategic investors make further $1.5m investment in Race

August 12, 2020

A$3m strategic investment from prominent biotech investors

July 12, 2020

Extension of time to repay loan through share buy-back

June 16, 2020

Impressive 40% response in Phase II Bisantrene AML Trial

June 15, 2020

Managing Director Resignation

May 20, 2020

Race starts preclinical breast cancer study for Bisantrene

May 13, 2020

Race Secures A$1.8m strategic placement

March 5, 2020

December 2019 Quarterly Report

January 29, 2020

Decks in 2020